Italian firm Takis develops world's first coronavirus vaccine |READ DETAILS
Afnews Editor
May 06, 2020
An Italian medical firm, Takis said it has developed the world's first vaccine that neutralises the coronavirus in human cells.
READ ALSO: Ebonyi Lawyer Arrested by DSS in 2021 Still in Custody Without Charge
According to tests carried out at Rome's infectious-disease Spallanzani Hospital, a single shot of the vaccine generates antibodies in mice.
Italian news agency ANSA reported that the antibodies can block the virus from infecting human cells.
READ ALSO: B00M: Reps Summons CBN Governor, IGP, Others, Threatens To Deal With Them
Luigi Aurisicchio, CEO of Takis, told ANSA that the Covid-19 candidate vaccine had neutralised the virus in human cells, for the first time.
READ ALSO: Accept Pantami's apologies - FG to Nigerians
"According to Spallanzani Hospital, we are the first in the world so far to have demonstrated a neutralisation of the coronavirus by a vaccine.
"We expect this to happen in humans too,ÔÇØ Aurisicchio told ANSA.
READ ALSO: Jim Iyke Sparks Outrage: "Doctors Are Trained Not to Heal - Sickness Is Their BusinessÔÇØ
After observing that five candidate vaccines generated a large number of antibodies, researchers selected the two with the best results.
READ ALSO: COVID-19: Abia State Task Force Visits Arochukwu LGA Again
All of the candidate vaccines currently being developed are based on the material genetic of DNA protein "spikeÔÇØ. They are injected with "electroporationÔÇØ technique, which consists of an intramuscular injection followed by a brief electrical impulse, helping the vaccine enter the cells.
READ ALSO: Abia YPP Guber Candidate, Chima Nwafor, Reveals Plans On Waste Management
Researchers at Takis believe that this makes their vaccine particularly effective for generating antibodies in the lung cells, the most vulnerable to coronavirus.
READ ALSO: REVEALED: How Common House Rats Can Kill - Shocking Truth Behind Silent Deaths in Nigerian Homes
Another Italian company ReiThera has said its coronavirus vaccine had shown a "strong immune responseÔÇØ in animals.
READ ALSO: Ebonyi State Govt Reacts To Court's Disbandment Of Ebubeagu | READ DETAILS
"The antibodies are able to prevent the infection and the T cells eliminate the virus that has already entered the organism,ÔÇØ it told news agency ANSA.
On Tuesday, Israel's Defence Minister Naftali Bennett claimed the country's main biological research institute IIBR has developed an antibody to the coronavirus that can attack the virus and neutralise it within the bodies of those who contract it.
READ ALSO: How a Nigerian Professor's AI System Could Predict Depression Before Symptoms Emerge
The statement, however, did not clarify whether human trials for the vaccine were conducted.
READ ALSO: Ebonyi Lawyer Arrested by DSS in 2021 Still in Custody Without Charge
The IIBR has conducted some clinical trials.
The researchers have identified the protein that is efficient in killing the virus in a patient's body, and the institute would be publishing a paper soon about the findings.
READ ALSO: B00M: Reps Summons CBN Governor, IGP, Others, Threatens To Deal With Them
So far, at least 254,532 people have died from Covid-19 since the outbreak first emerged in China last December.
READ ALSO: Accept Pantami's apologies - FG to Nigerians
More than 3,629,160 cases have been confirmed in 195 countries and territories.
Credit
Related Stories
How Nonchalant Attitude at Federal Medical Centre Umuahia Is Turning Accident Victims Into Casualties - Shocking Findings Emerge
How a Nigerian Professor's AI System Could Predict Depression Before Symptoms Emerge
Jim Iyke Sparks Outrage: "Doctors Are Trained Not to Heal - Sickness Is Their BusinessÔÇØ
Why Nigeria Must Declare a State of Emergency on Malaria - Hon. Amobi Ogah Reveals at National Retreat
'Buhari Died In London Hospital After Promising Nigerians Quality Healthcare' - Activist Adetoun Attacks Late Ex President
REVEALED: How Common House Rats Can Kill - Shocking Truth Behind Silent Deaths in Nigerian Homes
""
— Afnews Editor